Use of an innovative system and nanotechnology-based strategy for therapeutic applications of Gla-rich protein (GRP)
Introduction: Gla-rich protein (GRP) is a vitamin K-dependent protein (VKDP) acting as a calcification inhibitor and anti-inflammatory agent in cardiovascular and articular systems, and THP1 monocyte/macrophage cells [1,2]. Calcification and inflammation processes are known to be involved in the eti...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | テキスト |
| 言語: | 英語 |
| 出版事項: |
Taylor & Francis
2019
|
| 主題: | |
| オンライン･アクセス: | https://pmc.ncbi.nlm.nih.gov/articles/PMC7888969/ http://dx.doi.org/10.1080/07853890.2018.1561804 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|